Centessa Pharmaceuticals plcCNTA

那斯達克 · USD
16.81
-0.36
(-2.10%)
收盤 08/02 03:59 (UTC+8)
盤後 
(0%)
08/02 03:59 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • -
  • -
  • -
  • -
  • 0.07
  • -
  • -
  • -
  • -
  • 0.15
icon
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
2023/Q3
2023/Q2
2023/Q1
2022/Q4
營業收入淨額
15,000
-
-
-
-
6,853
-
-
-
-
營業成本
----------
營業毛利
15,000
-
-
-
-
-
-
-
-
-
營業費用
------40,20947,01948,87741,603
研發費用
33,44360,87433,90332,81522,65229,71628,19033,67332,82627,835
推銷及管理費用
12,33413,70612,50211,16513,43812,31512,01913,34616,05113,768
非經常性項目費用
----------
其他營業費用
----------
營業利益
-30,777
-74,580
-46,405
-43,980
-36,090
-35,178
-40,209
-47,019
-48,877
-41,603
其他收入及費用
8,916-33,2207,0043,3941,0542,0551,2765321,185-275
利息費用
2,8772,4792,5572,5252,5292,5702,5412,4502,3451,959
稅前純益
-24,738
-110,279
-41,958
-43,111
-37,565
-35,693
-41,474
-48,937
-50,037
-43,837
所得稅
1,3971,0506087054811,144-2,826-24,051677-664
稅後純益
-26,135
-111,329
-42,566
-43,816
-38,046
-36,837
-38,648
-24,886
-50,714
-43,173
基本每股稅後盈餘(元)
-0.20-0.84-0.37-0.40-0.38--0.40-0.26-0.53-0.45
稀釋每股稅後盈餘(元)
-0.20-0.91-0.37-0.40-0.38-0.37-0.40-0.27-0.53-0.45
基本平均股數(千股)
133033.00132050.00116253.00109489.0099887.00-96648.0095162.0094937.0094603.00
稀釋平均股數(千股)
133033.00132050.00116253.00109489.0099887.00-96648.0095162.0094937.0094603.00
還原基本每股稅後盈餘(元)
-0.20-0.84-0.37-0.40-0.38--0.40-0.26-0.53-0.45
還原稀釋每股稅後盈餘(元)
-0.20-0.91-0.37-0.40-0.38-0.37-0.40-0.27-0.53-0.45
還原基本平均股數(千股)
133,033132,050116,253109,48999,887-96,64895,16294,93794,603
還原稀釋平均股數(千股)
133,033132,050116,253109,48999,887-96,64895,16294,93794,603
EBITDA(千元)
-23,414-107,570-39,165-40,350-34,796-32,877-38,695-46,250-47,603-41,842

大家都在看

HOT